ReviewOncotarget2018
Implications of KRAS mutations in acquired resistance to treatment in NSCLC.
Marzia Del Re et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this papercites it
ReviewOncotarget2018
Marzia Del Re et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.